Relationships between hemodynamic alterations and Child-Pugh Score in patients with cirrhosis

Dinc Dincer1, Fatih Besisk, Onur Demirkol

  • 1Division of Gastroenterology, Medical Faculty of Istanbul University of Istanbul, Turkey. ddinc@akdeniz.edu.tr

Hepato-Gastroenterology
|October 6, 2005
PubMed

Insights

In liver cirrhosis, higher Child-Pugh scores correlate with increased angiotensin, aldosterone, and cardiac output, alongside decreased water clearance. These hemodynamic changes, including altered blood flow, occur early in cirrhosis progression.

Area of Science:

  • Cardiology
  • Hepatology
  • Nephrology

Background:

  • Liver cirrhosis leads to significant hemodynamic alterations.
  • Understanding these changes and their correlation with disease severity is crucial.

Purpose of the Study:

  • To evaluate central and nonsplanchnic hemodynamic alterations in liver cirrhosis.
  • To assess the correlation between the Child-Pugh Score and these hemodynamic changes.

Main Methods:

  • Evaluated angiotensin-I, aldosterone, femoral blood flow, cardiac index, free water clearance, and renal blood flow index.
  • Studied 30 cirrhotic patients and 10 healthy controls.

Main Results:

  • Child-Pugh Score positively correlated with angiotensin-I, aldosterone, cardiac index, and renal blood flow index.
  • Child-Pugh Score negatively correlated with free water clearance and femoral blood flow.
  • Hemodynamic alterations begin before ascites formation.

Conclusions:

  • Increased Child-Pugh Score in cirrhosis is linked to higher angiotensin, aldosterone, cardiac output, and non-splanchnic vasoconstriction.
  • Progressive decrease in free water clearance and renal perfusion occurs with worsening cirrhosis.
  • Hyperdynamic circulation is an early event, independent of central blood volume.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...